A Study to Evaluate Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction and Control Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2017
At a glance
- Drugs Evogliptin (Primary)
- Indications Liver dysfunction
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 21 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 21 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
- 20 Aug 2017 Status changed from not yet recruiting to recruiting.